1. Green, P.H. and C. Cellier, Celiac disease. New england journal of medicine, 2007. A357(17): 1731-1743. [
DOI:10.1056/NEJMra071600]
2. Schuppan, D. and K.-P. Zimmer, The diagnosis and treatment of celiac disease. Deutsches Arzteblatt international, 2013. A 110(49): 835-846. [
DOI:10.3238/arztebl.2013.0835]
3. Abadie, V., et al., Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annual review of immunology, 2011. 29: 493-525. [
DOI:10.1146/annurev-immunol-040210-092915]
4. Glissen Brown, J.R. and P. Singh, Coeliac disease. Paediatr Int Child Health, 2019. A 39(1): 23-31. [
DOI:10.1080/20469047.2018.1504431]
5. Lebwohl, B., D.S. Sanders, and P.H. Green, Coeliac disease. The Lancet, 2018. A 391(10115): 70-81. [
DOI:10.1016/S0140-6736(17)31796-8]
6. Rubio-Tapia, A., et al., ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease [Practice Guidelines]. Am J Gastroenterol, 2013.656-76:(5). [
DOI:10.1038/ajg.2013.79]
7. Gujral, N., H.J. Freeman, and A.B. Thomson, Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World journal of gastroenterology: WJG, 2012. 18(42): 6036. [
DOI:10.3748/wjg.v18.i42.6036]
8. Rahmati, A., et al., Correlation of tissue transglutaminase antibody with duodenal histologic marsh grading. Middle East journal of digestive diseases, 2014. 6(3): 131.
9. Fasano, A., et al., Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Archives of internal medicine, 2003. 163(3): 286-292. [
DOI:10.1001/archinte.163.3.286]
10. Caproni, M., et al., Guidelines for the diagnosis and treatment of dermatitis herpetiformis. Journal of the European Academy of Dermatology and Venereology, A 2009. 23(6): 633-638. [
DOI:10.1111/j.1468-3083.2009.03188.x]
11. Catassi, C. and A. Fasano, Clinical practice: Celiac disease. N Engl J Med, 2012. 367: A 2419-26. [
DOI:10.1056/NEJMcp1113994]
12. Salmi, T.T., Dermatitis herpetiformis. Clin Exp Dermatol, 2019. 44(7): 728-731. [
DOI:10.1111/ced.13992]
13. Lionetti, E. and C. Catassi, New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. International reviews of immunology, 2011. A 30(4): 219-231. [
DOI:10.3109/08830185.2011.602443]
14. Tavakkoli, H., et al., Serologic celiac disease in patients with inflammatory bowel disease. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2012. 17(2): 154.
15. Ehsani-Ardakani, M.J., et al., Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease. Arch Iran Med, A 2013. 16(2): 78-82.
16. Lee, S.K., et al., Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointestinal endoscopy, 2003. 57(2): 187-191. [
DOI:10.1067/mge.2003.54]
17. Ghazzawi, Y., et al., Mucosal healing in children with treated celiac disease. Journal of pediatric gastroenterology and nutrition, A 2014. 59(2): 229-231. [
DOI:10.1097/MPG.0000000000000390]
18. Wahab, P.J., J.W. Meijer, and C.J. Mulder, Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. American journal of clinical pathology, 2002. 118(3): 459-463. [
DOI:10.1309/EVXT-851X-WHLC-RLX9]
19. Ludvigsson, J.F., et al., Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 2014. 63(8): 1210- A 1228. [
DOI:10.1136/gutjnl-2013-306578]
20. Presutti, R.J., et al., Celiac disease. American family physician, 2007. 76(12): 1795-1802.
21. Fasano, A., Clinical presentation of celiac disease in the pediatric population. Gastroenterology, 2005. 128(4): S68-S73. [
DOI:10.1053/j.gastro.2005.02.015]
22. Rostom, A., J.A. Murray, and M.F. Kagnoff, American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology, 2006. 131(6): 1981-2002. [
DOI:10.1053/j.gastro.2006.10.004]
23. Haines, M.L., R.P. Anderson, and P.R. Gibson, Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther, 2008. A 28(9): 1042-66. [
DOI:10.1111/j.1365-2036.2008.03820.x]
24. Lebwohl, B., D.S. Sanders, and P.H.R. Green, Coeliac disease. Lancet, 2018. A 391(10115): 70-81. [
DOI:10.1016/S0140-6736(17)31796-8]
25. Rubio-Tapia, A., et al., ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol, 2013. A 108(5): 656-76; quiz 677. [
DOI:10.1038/ajg.2013.79]
26. Baghbanian, M. and M. Akhondi-Meybodi, Evaluation of Clinical Symptoms of Patients with Celiac Disease Referred to Khatamolanbia Clinic in Yazd City in 2014. The Journal of Shahid Sadoughi University of Medical Sciences, 2020. 28(5): 2673.2680. [
DOI:10.18502/ssu.v28i5.3975]
27. Lionetti, E. and C. Catassi, New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol, 2011. 30(4): 219-31. [
DOI:10.3109/08830185.2011.602443]
28. Rostami, K., et al., Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol, 1999. A 94(4): 888-94. [
DOI:10.1016/S0002-9270(99)00038-6]
29. Tavakkoli, H., et al., Serologic celiac disease in patients with inflammatory bowel disease. J Res Med Sci, 2012. 17(2): 154-8.
30. Shahraki, T., et al., Clinical and laboratory findings of celiac disease in patients referred to Children Medical Center (Tehran Iran). Journal of Babol University of Medical Sciences, 2009. 11(4): 69-74.
31. Rubio-Tapia, A., et al., American College of Gastroenterology guidelines update: Diagnosis and management of celiac disease. Official journal of the American College of Gastroenterology| ACG, 2023. 118(1): 59-76. [
DOI:10.14309/ajg.0000000000002075]
32. Ehsani-Ardakani, M.J., et al., Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease. Archives of Iranian medicine, 2013. 16(2): 0-0.
33. Singh, P., et al., Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol, 2018. A 16(6): 823-836.e2. [
DOI:10.1016/j.cgh.2017.06.037]
34. Shahbazkhani, B., et al., High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol, A 2003. 15(5): 475-8. [
DOI:10.1097/00042737-200305000-00003]
35. Shamir, R., et al., The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol, 2002. A 97(10): 2589-94. [
DOI:10.1016/S0002-9270(02)04386-1]
36. Challar, M.H., et al., Prevalence of asymptomatic celiac disease in a Syrian population sample. Journal of the Arab Board of Medical Specializations, 2004. 6(2): 155- A 60.
37. Tatar, G., et al., Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci, 2004. 49(9): A 1479-84. [
DOI:10.1023/B:DDAS.0000042250.59327.91]
38. Gursoy, S., et al., The prevalence of unrecognized adult celiac disease in Central Anatolia. J Clin Gastroenterol, 2005. 39(6): A 508-11. [
DOI:10.1097/01.mcg.0000165664.87153.e1]
39. Crowe, S.E., Putting celiac disease in perspective: Pathogenesis, comorbidity and transition of care. United European Gastroenterol J, 2020. 8(2): 129-130. [
DOI:10.1177/2050640620908460]
40. Ch'ng, C.L., M.K. Jones, and J.G. Kingham, Celiac disease and autoimmune thyroid disease. Clin Med Res, 2007. 5(3): 184-92. [
DOI:10.3121/cmr.2007.738]